Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Copley

Executive Summary

Copley: VP-Scientific Affairs Jerome Skelly resigns. Skelly, who headed FDA's Division of Biopharmaceutics from 1983 to 1988, will continue to work for Copley as an outside R&D consultant. Copley is considering internal and external candidates for the VP position. The company is also considering whether further workforce reductions are necessary. Copley is scheduled for an initial appearance before Boston Federal Judge Joseph Tauro during the week of June 9 to review a $10.7 mil. fraud settlement reached with the U.S. Attorney's office. The generic drug maker is a subsidiary of Hoechst AG ("The Pink Sheet" June 2, T&G-10)...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030323

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel